Efficacy of phage cocktail AB-SA01 therapy in diabetic mouse wound infections caused by multidrug-resistant Staphylococcus aureus

Safety of bacteriophage therapy in severe Staphylococcus aureus infection

(2020) Aleksandra Petrovic Fabijan et al.   Nature Microbiology

Design and Preclinical Development of a Phage Product for the Treatment of Antibiotic-Resistant Staphylococcus aureus Infections

(2019) Susan Lehman et al.   Viruses-Basel

Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection

(2019) Johanna M. Sweere et al.   SCIENCE

The cost of diabetic foot ulcers and amputations to the National Health Service in England

(2019) M. Kerr et al.   DIABETIC MEDICINE

The Human Gut Virome Is Highly Diverse, Stable, and Individual Specific

(2019) Andrey N. Shkoporov et al.   Cell Host & Microbe

Diabetic Foot Ulcers and Their Recurrence

(2017) David G. Armstrong et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-Term Safety of Topical Bacteriophage Application to the Frontal Sinus Region

(2017) Amanda J. Drilling et al.   Frontiers in Cellular and Infection Microbiology

Pro- and anti-inflammatory responses of peripheral blood mononuclear cells induced by Staphylococcus aureus and Pseudomonas aeruginosa phages

(2017) Jonas D. Van Belleghem et al.   Scientific Reports

Classic Spotlight: Plate Counting You Can Count On

(2016) George A. O'Toole   JOURNAL OF BACTERIOLOGY

Bacteriophage treatment of intransigent diabetic toe ulcers: a case series

(2016) R. Fish et al.   Journal of Wound Care

Epidemiology of Methicillin-Resistant Staphylococcus aureus Diabetic Foot Infections in a Large Academic Hospital: Implications for Antimicrobial Stewardship

(2016) Kelly R. Reveles et al.   PLoS One

Existence of a ColonizingStaphylococcus aureusStrain Isolated in Diabetic Foot Ulcers

(2015) Nourreddine Messad et al.   DIABETES

High burden of diabetic foot infections in the top end of Australia: An emerging health crisis (DEFINE study)

(2015) Robert J. Commons et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Diabetic foot infections: what have we learned in the last 30 years?

(2015) Ilker Uçkay et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Combined Use of Bacteriophage K and a Novel Bacteriophage To Reduce Staphylococcus aureus Biofilm Formation

(2014) D. R. Alves et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Mortality Rates and Diabetic Foot Ulcers

(2014) Jeffrey M. Robbins et al.   JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION

Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial

(2014) D.D. Rhoads et al.   Journal of Wound Care

Burden of Diabetic Foot Ulcers for Medicare and Private Insurers

(2013) J. Bradford Rice et al.   DIABETES CARE

Phage cocktails and the future of phage therapy

(2013) Benjamin K Chan et al.   Future Microbiology

Bacteriophage Therapy for Staphylococcus aureus Biofilm–Infected Wounds

(2013) Akhil K. Seth et al.   PLASTIC AND RECONSTRUCTIVE SURGERY

Co-Therapy Using Lytic Bacteriophage and Linezolid: Effective Treatment in Eliminating Methicillin Resistant Staphylococcus aureus (MRSA) from Diabetic Foot Infections

(2013) Sanjay Chhibber et al.   PLoS One

A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens

(2013) Xavier Wittebole et al.   Virulence

Murine Model of Wound Healing

(2013) Louise Dunn et al.   Jove-Journal of Visualized Experiments

Going viral: next-generation sequencing applied to phage populations in the human gut

(2012) Alejandro Reyes et al.   NATURE REVIEWS MICROBIOLOGY

What is needed for phage therapy to become a reality in Western medicine?

(2012) Harald Brüssow   VIROLOGY

Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models

(2011) M C Deeds et al.   LABORATORY ANIMALS

Diagnostic Necropsy and Selected Tissue and Sample Collection in Rats and Mice

(2011) Christina M. Parkinson et al.   Jove-Journal of Visualized Experiments

The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure?

(2010) Jean-Paul Pirnay et al.   PHARMACEUTICAL RESEARCH

Bacteriophage Cocktail for the Prevention of Biofilm Formation by Pseudomonas aeruginosa on Catheters in an In Vitro Model System

(2009) W. Fu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Topical Antimicrobial Therapy for Treating Chronic Wounds

(2009) Benjamin A. Lipsky et al.   CLINICAL INFECTIOUS DISEASES

Preventing biofilms of clinically relevant organisms using bacteriophage

(2009) Rodney M. Donlan   TRENDS IN MICROBIOLOGY

Bacteriophage Therapy and the Mutant Selection Window

(2008) B. J. Cairns et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY